Stephanie Huberlant
Overview
Explore the profile of Stephanie Huberlant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ranisavljevic N, Bonneau M, Rougier N, Hamamah S, Anahory T, Serand C, et al.
Fertil Steril
. 2024 Oct;
PMID: 39433204
No abstract available.
2.
Morsli M, Gimenez E, Magnan C, Salipante F, Huberlant S, Letouzey V, et al.
Eur J Clin Microbiol Infect Dis
. 2024 Aug;
43(10):1869-1881.
PMID: 39096320
Purpose: The vaginal microbiota offers valuable insights into women's sexual health and the risk of developing sexually transmitted infections (STIs) and bacterial vaginosis. Despite the public health implications of changes...
3.
Sigala J, Poirey S, Robert J, Pouget O, Mura T, Huberlant S, et al.
PLoS One
. 2024 Jul;
19(7):e0307080.
PMID: 39008497
Background: In the field of male infertility, when sperm is normal/subnormal, a few "add-on" routine tests can complete the basic semen examination. Objectives: The aim of this study was to...
4.
David M, Vintejoux E, Kucharczak F, Brouillet S, Rougier N, Huberlant S
J Gynecol Obstet Hum Reprod
. 2023 Nov;
53(1):102692.
PMID: 37979690
Introduction: The prevalence of Caesarean delivery is rising steadily worldwide, and it is important to identify its future impact on fertility. A number of articles have been published on this...
5.
Pouget O, Zemmache Z, Kabani S, Alsawaf M, Zuna I, Bonneau M, et al.
Zygote
. 2023 May;
31(4):373-379.
PMID: 37198964
The live birth rate following embryo transfer is comparable between spontaneous, stimulated and artificial cycles. However, the pregnancy loss rate appears elevated with hormonal therapy, possibly due to luteal insufficiency....
6.
Leborne P, Huberlant S, Masia F, de Tayrac R, Letouzey V, Allegre L
Sci Rep
. 2022 Dec;
12(1):21800.
PMID: 36526707
The main aim of the study was to evaluate severe post-operative complications following deep endometriosis surgery in a tertiary referral centre. This is a retrospective cohort study that included women...
7.
Ranisavljevic N, Huberlant S, Montagut M, Alonzo P, Darne B, Languille S, et al.
Front Endocrinol (Lausanne)
. 2022 Jun;
13:892753.
PMID: 35757393
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=139019, identifier 139019.
8.
Schultz C, Huberlant S, Letouzey V, Moranne O
J Nephrol
. 2022 Mar;
35(9):2433-2435.
PMID: 35239174
We report the case of a 31-year-old patient on chronic hemodialysis for 17 years, after two failed kidney grafts, presently on daily home hemodialysis. She underwent follicle puncture for oocyte...
9.
Weyers S, Capmas P, Huberlant S, Dijkstra J, Hooker A, Hamerlynck T, et al.
J Minim Invasive Gynecol
. 2021 Aug;
29(1):151-157.
PMID: 34343712
Study Objective: To evaluate the safety and potential efficacy of a novel degradable polymer film (DPF) designed to act as a 7-day barrier to prevent intrauterine adhesions (IUAs) after hysteroscopic...
10.
Huberlant S, Leprince S, Allegre L, Warembourg S, Leteuff I, Taillades H, et al.
J Minim Invasive Gynecol
. 2020 Nov;
28(7):1384-1390.
PMID: 33152532
Study Objective: To study the safety of a degradable polymeric film (DPF) and its efficacy on reducing the risk of intrauterine-adhesion (IUA) formation in a rat model. Design: A series...